Chronic Sleep Deprivation Impaired Bone Formation in Growing Rats and Down-Regulated PI3K/AKT Signaling in Bone Tissues
DOI: https://doi.org/10.2147/NSS.S351850
2022-04-14
Nature and Science of Sleep
Abstract:Xiaoye Duan, 1, 2 Qi Pan, 1 Lixin Guo 1, 2 1 Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China; 2 Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China Correspondence: Lixin Guo, Email Background: This study aimed to assess the effects of chronic sleep deprivation (CSD) on bone metabolism in growing rats and the likely underlying mechanism. Methods: Twenty 5-week-old male Wistar rats and randomly divided into the CSD and normal control (NC) groups after one-week acclimatization. After a 6-week intervention of sleep deprivation, the distal femurs of both groups were harvested for micro-computed tomography scans and histological analysis. Meanwhile, the femur tissues were measured the mRNA and protein expression via RNA sequencing and immunohistochemical analysis. Serum bone turnover markers were evaluated at 0, 2, 4, and 6 weeks. Results: CSD impaired the bone growth, showing an imbalance of bone turnover status, dysphasia in the metaphysis growth plate, and deterioration of bone microarchitecture. Further, CSD suppressed bone formation, showing that the expression of osteogenesis-related proteins (col1α 1 and osteocalcin) and mRNA ( igf1, bglap, runx2, col1α 1, pth1r ) are down-regulated. Differentially expressed genes were detected, and functional enrichment analyses revealed that the PI3K/AKT pathway was significantly down-regulated in the CSD group. Conclusion: These results suggest that CSD can significantly impaire bone health, and it may exert these effects in part by suppressing bone formation and osteoblast differentiation, and inactivating the PI3K/AKT signaling pathway. Keywords: chronic sleep deprivation, sleep loss, growth, bone formation, RNA sequencing, PI3K/AKT pathway Sleep deprivation (SD), recognized as a public health epidemic, is associated with adverse health conditions, 1 yet little is known about the association between sleep and bone health. A recent study for a cohort in children and adolescents, showed that the subjects with inadequate sleep duration often exhibit abnormal bone growth with low bone density or bone stiffness, suggesting that sleep homeostasis plays an important role in bone growth. 2 Some studies have shown that long-term sleep disorders are also risk factors for osteoporosis, 3,4 and inadequate sleep duration has been linked to bone growth retardation in children and bone mass loss in adolescents. 2 However, additional research in this area is needed to determine how sleep deprivation impairs skeletal health and the skeletal features and underlying mechanisms. Under healthy conditions, bone is maintained by the constant process of bone remodeling. Normal bone remodeling maintains a balance between bone resorption and formation to maintain bone density. Osteoblasts are generated from the osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs), which are common precursors for osteoblasts. The direction of BMSC differentiation depends on specific regulatory factors. RUNX family transcription factor 2 ( RUNX-2 ) acts as a key transcriptional modulator that mediates the conversion of BMSCs into osteoblasts. 5 As osteoblasts mature, they begin producing the bone extracellular matrix by secreting bone matrix proteins including collagen type I alpha 1 (Col1α1), osteocalcin (OCN), and alkaline phosphatase (ALP). Type I collagen is the main constituent of bone, comprising the non-mineralized bone matrix. Mature osteoblasts express ALP, Col1α1, OCN, and osterix. 6 Insulin-like growth factor-1 (IGF-1) is also a key factor for bone formation that promotes osteoblast growth, differentiation, cell cycle progression, and increases cell activity. 7 The action of neuropeptides among people with sleep disorders may also take under consideration. For example, orexin A, as a kind of hypothalamic peptides, may target on rat osteoblasts affecting metabolism, especially during their early stages of differentiation into mature osteoblasts. 8,9 Previous clinical studies and animal experiments have failed to reach a consensus on the effect of sleep deprivation on bone growth and development, and have not indicated bone metabolic status and the related possible mechanisms associated with chronic sleep deprivation (CSD). 10,11 In our study, RNA sequencing (RNA-seq) analysis suggested that several signaling pathways of CSD, including phosphatidylinositol 3-kinase (PI3K)/AKT, were found to play a role in chondrogen -Abstract Truncated-
neurosciences,clinical neurology